Lactoferrin-derived Peptides Active towards Influenza: Identification of Three Potent Tetrapeptide Inhibitors

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Scala, Maria Carmina ^a   Sala, Marina ^a   Pietrantoni, Agostina ^b   Spensiero, Antonia ^a   Di Micco, Simone ^a   Agamennone, Mariangela ^c   Bertamino, Alessia ^a   Novellino, Ettore ^d   Bifulco, Giuseppe ^a   Gomez Monterrey, Isabel M ^d   Superti, Fabiana ^b   Campiglia, Pietro ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; LACTOFERRIN; PEPTIDE;

ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECT; HEMAGGLUTINATION; HEMAGGLUTINATION TEST; HUMAN; IMMUNOLOGY; INFLUENZA; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORTHOMYXOVIRIDAE; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; HEMAGGLUTINATION TESTS; HEMAGGLUTINATION, VIRAL; HUMANS; INFLUENZA, HUMAN; LACTOFERRIN; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; ORTHOMYXOVIRIDAE; PEPTIDES; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 85028949949     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-10492-x     Document Type: Article

References (52)

1. Legrand, D., Mazurier, J., Colavizza, D., Montreuil, J. & Spik, G. Properties of the iron-binding site of the N-terminal lobe of human and bovine lactotransferrins. Importance of the glycan moiety and of the non-covalent interactions between the N-and C-terminal lobes in the stability of the iron-binding site. Biochem J. 266, 575-581 (1990).
2. Moore, S. A., Anderson, B. F., Groom, C. R., Haridas, M. & Bake, E. N. Three-dimensional structure of diferric bovine lactoferrin at 2. 8 uA resolution. J Mol Biol. 274, 222-236 (1997).
3. Gennaro, R., Dewald, B., Horisberger, U., Gubler, H. U. & Baggiolini, M. A novelty of cytoplasmic granule in bovine neutrophils. J Cell Biol. 96, 1651-1661 (1983).
4. Levay, P. F. & Viljoen, M. Lactoferrin: A general review. Haematologica. 80, 252-267 (1995).
5. Vorland, L. H. Lactoferrin: A multifunctional glycoprotein. APMIS. 107, 971-981 (1999).
6. Van der Strate, B. W. A., Beljaars, L., Molema, G., Harmsen, M. C. & Meijer, D. K. F. Antiviral activities of lactoferrin. Antivir Res. 52, 225-239 (2001).
7. Marchetti, M. & Superti, F. Antiviral activity of lactoferrin. In Recent Developments in Antiviral Research; Trivandrum: Transworld Research Network. 1, 193-203 (2001).
8. Harmsen, M. C. et al. Antiviral effects of plasma and milk proteins: lactoferrin shows a potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J Infec. Dis. 172, 380-388 (1995).
9. Beljaars, L. et al. Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. Antivir Res. 63, 197-208 (2004).
10. Hasegawa, K., Motsuchi, W., Tanaka, S. & Dosako, S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn J. Med. Sci. Biol. 47, 73-85 (1994).
11. Marchetti, M., Trybala, E., Superti, F., Johansson, M. & Bergstrom, T. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology. 18, 405-413 (2004).
12. Marchetti, M., Ammendolia, M. G. & Superti, F. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin. Biochimie. 91, 155-159 (2009).
13. Ammendolia, M. G., Marchetti, M. & Superti, F. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells. Antivir Res. 76, 252-262 (2007).
14. Yi, M., Kaneko, S., Yu, D. Y. & Murakami, S. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol. 71, 5997-6002 (1997).
15. Murphy, M. E. et al. In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus. Arch. Virol. 145, 1571-1582 (2000).
16. Hara, K. et al. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol. Res. 24, 228-235 (2002).
17. Sano, H., Nagai, K., Tsutsumi, H. & Kuroki, Y. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur. J. Immunol. 33, 2894-2902 (2003).
18. Chien, Y. J., Chen, W. J., Hsu, W. L. & Chiou, S. S. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Virology. 379, 143-151 (2008).
19. Carvalho, C. A. et al. Inhibition of Mayaro virus infection by bovine lactoferrin. Virology. 452-453, 297-302 (2014).
20. Pietrantoni, A., Fortuna, C., Remoli, M. E., Ciufolini, M. G. & Superti, F. Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate. Viruses. 7, 480-495 (2015).
21. Pietrantoni, A. et al. Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro. Biometals. 23, 465-475 (2010).
22. Pietrantoni, A., Ammendolia, M. G. & Superti, F. Bovine lactoferrin: Involvement of metal saturation and carbohydrates in the inhibition of influenza virus infection. Biochem. Cell. Biol. 90, 442-448 (2012).
23. Ammendolia, M. G. et al. Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus. Pathog. Glob. Health. 106, 12-19 (2012).
24. Wiley, D. C. & Skehel, J. J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann. Rev. Biochem. 56, 365-94 (1987).
25. Russell, R. J. et al. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology. 325, 287-296 (2004).
26. Gamblin, S. J. & Skehel, J. J. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J. Biol. Chem. 285, 28403-28409 (2010).
27. Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science. 324, 246-251 (2009).
28. Superti, F., Agamennone, M., Ammendolia, M. G., Pietrantoni, A., Lannutti, F. Lactoferrin derived peptides for use as broadspectrum inhibitors of Influenza virus infection. WO2013072946; Istituto Superiore Di Sanita, Universita Degli Studi "G. D'annunzio" (IT) (2014).
29. Navratilova, I. & Hopkins, A. L. Fragment Screening by Surface Plasmon Resonance. ACS Med. Chem. Lett. 1, 44-48 (2010).
30. Wuthrich, K. NMR of Proteins and Nucleic Acids. (John Wiley & Sons: New York, 1986).
31. Piantini, U., Sorensen, O. W. & Ernst, R. R. Multiple quantum filters for elucidating NMR coupling networks. J. Am. Chem. Soc. 104, 6800-6801 (1982).
32. Bax, A. & Davis, D. G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65, 355-360 (1985).
33. Macura, S. & Ernst, R. R. Elucidation of cross relaxation in liquids by two-dimensional N. M. R. spectroscopy. Mol. Phys. 41, 95-117 (1980).
34. Guntert, P., Mumenthaler, C. & Wuthrich, K. Torsion angle dynamics for NMR structure calculation with the new program D1. J. Mol. Biol. 273, 283-298 (1997).
35. Hutchinson, E. G. & Thornton, J. M. PROMOTIF-a program to identify and analyze structural motifs in proteins. Protein Sci. 5, 212-220 (1996).
36. Di Micco, S. et al. Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222. Bioorg. & Med. Chem. 16, 8635-8642 (2008).
37. Maulucci, N. et al. Molecular Insights into Azumamide E Histone Deacetylases Inhibitory Activity. J. Am. Chem. Soc. 129, 3007-3012 (2007).
38. Bax, A. & Davis, D. G. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 63, 207-213 (1985).
39. Zeng, L. Y., Yang, J. & Liu, S. Investigational hemagglutinin-targeted influenza virus inhibitors. Expert Opin. Investig. Drugs. 26(1), 63-73 (2017).
40. Makinson, A. & Reynes, J. The fusion inhibitor enfuvirtide in recent antiretroviral strategies. Curr. Opin. HIV AIDS. 4, 150-158 (2009).
41. Skalickova, S. et al. Perspective of Use of Antiviral Peptides against Influenza Virus. Viruses 7, 5428-5442 (2015).
42. Agamennone, M., Pietrantoni, A. & Superti, F. Identification of Small Molecules Acting Against H1N1 Influenza A Virus. Virology. 488, 249-258 (2016).
43. Gaush, C. R. & Smith, T. F. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl. Microbiol. 16, 588-594 (1968).
44. Rimmelzwaan, G. F., Baars, M., Claas, E. C. & Osterhaus, A. D. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J. Virol. Methods. 74, 57-66 (1998).
45. Atherton, E. & Sheppard, R. C. Solid-Phase Peptide Synthesis: A Practical Approach (Oxford, U. K., 1989).
46. Stewart, J. M. & Young, J. D. Solid Phase Peptide Synthesis (Pierce Chemical: Rockford, IL, 1984).
47. Sala, M. et al. Development and Identification of a Novel Anti-HIV-1 Peptide Derived by Modification of the N-Terminal Domain of HIV-1 Integrase. Front. Microbiol. 7, 845 (2016).
48. GE Healthcare. Biacore Sensor Surface Handbook Ch. 4, 39-40 (Ed. AB, 2008).
49. Terracciano, S. et al. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. Bioorg. & Med. Chem. 18, 3252-3260 (2010).
50. Marion, D. & Wuthrich, K. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 113, 967-974 (1983).
51. Goddard, T. D. & Kneller, D. G. SPARKY 3, University of California, San Francisco.
52. Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25(13), 1605-1612 (2004).